ASRT vs TOST · rev $125.0M vs P/E 161, rev $3.54B
Assertio Therapeutics Inc (ASRT) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
ASRT currently screens at market cap $151.5M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the ASRT and TOST stock pages for the full models.
Not investment advice.